Arsenate toxicity in human erythrocytes: Characterization of morphologic changes and determination of the mechanism of damage

Journal of Toxicology and Environmental Health - Part A

Volumn 53, Issue 5, 1998, Pages 345-355

  Winski, Shannon L ^a   Carter, Dean E ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENATE SODIUM; ARSENITE SODIUM;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; ECHINOCYTE; ERYTHROCYTE DISORDER; FEMALE; HEMOLYSIS; HUMAN; MALE; MICROSCOPY; NORMAL HUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TARGET CELL; TOXICITY TESTING;

ADENOSINE TRIPHOSPHATE; ADULT; ARSENATES; ARSENIC; ARSENITES; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; FEMALE; HUMANS; MALE; SODIUM COMPOUNDS;

EID: 0032513208     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/009841098159213     Document Type: Article

References (40)

1. Agency for Toxic Substances and Disease Registry. 1993. Toxicological Profile for Arsenic. U.S. Department of Health and Human Services, Public Health Service, April.
2. Aposhian, H. V. 1989. Biochemical toxicology of arsenic. Rev. Biochem. Toxicol. 10:265-299.
3. Armstrong, C. W., Stroube, R. B., Rubio, T., Siudyla, E. A., and Miller G. B. 1984. Outbreak of fatal arsenic poisoning caused by contaminated drinking water. Arch. Environ. Health 39:276-279.
4. Bell, A. 1992. Erythropoiesis and erythrocyte physiology. In Clinical hematology: Principles, proce- dures, correlations, eds. C. A. Lotspeich-Steininger, E. A. Stiene-Martin, and J. A. Keopke, pp. 65-71. Philadelphia: J. B. Lippincott.
5. Bessis, M. 1973. Red cell shapes. An illustrated classification and its rationale. Section I. In Red cell shape. Physiology, pathology, ultrastructure, eds. M. Bessis, R. I. Weed, and P. F. Lebond, pp. 1-26. New York: Springer-Verlag.
6. Beutler, E. 1984. Red cell metabolism: A manual of biochemical methods, 3rd ed., pp. 122-124. Orlando, FL: Grune and Stratton.
7. Braasch, D. 1971. Red cell deformability and capillary blood flow. Physiol. Rev. 51:679-701.
8. Crane, R. K., and Lipmann, F. 1953. The effect of arsenate on aerobic phosphorylation. J. Biol. Chem. 201:235-243.
9. Cullen, W. R., and Reimer, K. J. 1989. Arsenic speciation in the environment. Chem. Rev. 89:713-764.
10. Delnomdedieu, M., Basti, M. M., Styblo, M., Otvos, J. D., and Thomas, D. J. 1994. Complexation of arsenic species in rabbit erythrocytes. Chem. Res. Toxicol. 7:621-627.
11. Delnomdedieu, M., Styblo, M., and Thomas, D. J. 1995. Time dependence of accumulation and binding of inorganic and organic arsenic species in rabbit erythrocytes. Chem. Biol. Interact. 98:69-83.
12. Del Razo, L. M., Arellano, M. A., and Cebrian, M. E. 1990. The oxidation states of arsenic in well-water from a chronic arsenicism area of northern Mexico. Environ. Pollut. 64:143-153.
13. Fincher, R.-M. E., and Koerker, R. M. 1987. Long-term survival in acute arsenic encephalopathy: Follow-up using newer measures of electrophysiologic parameters. Am. J. Med. 82:549-552.
14. Franke, K. W., and Moxon, A. L. 1936. A comparison of the minimum fatal doses of selenium, tellurium, arsenic and vanadium. J. Pharmacol. Exp. Ther. 58:454-459.
15. Goldsmith, S., and From, A. H. L. 1980. Arsenic-induced atypical ventricular tachycardia. N. Engl. J. Med. 303:1 096-1097.
16. Gresser, M. J. 1981. ADP-arsenate: Formation by submitochondrial particles under phosphorylating conditions. J. Biol. Chem. 256:5981-5983.
17. Hasegawa, S., Hiruma, H., Uyesaka, N., Noguchi, C. T., Schechter, A. N., and Rodgers, G. P. 1995. Filterability of mixtures of sickle and normal erythrocytes. Am. J. Hematol. 50:91-97.
18. IARC. 1980. Arsenic and arsenic compounds. Monogr. Eval. Carcinogen. Risk Chem. Hum. 23:37141.
19. Kaul, D. K., Chen, D., and Zhan, J. 1994. Adhesion of sickle cells to vascular endothelium is critically dependent on changes in density and shape of the cells. Blood 83:3006-3017.
20. Kenney, L. J., and Kaplan, J. H. 1988. Arsenate substitutes for phosphate in the human red cell sodium pump and anion exchanger. J. Biol. Chem. 263:7954-7960.
21. Kyle, R. A., and Pease, G. L. 1965. Hematologic aspects of arsenic intoxication. N. Engl. J. Med. 273:18-23.
22. Labadie, H., Stoessel, P., Callard, P., and Beaugrand, M. 1990. Hepatic venoocclusive disease and perisinusoidal fibrosis secondary to arsenic poisoning. Gastroenterology 99:1140-1143.
23. LaCelle, P. L. 1970. Alteration in membrane deformability in hemolytic anemias. Sem. Hematol. 7:355-371.
24. Lagerkvist, B., Linderholm, H., and Nordberg, G. F. 1986. Vasospastic tendency and Raynaud's phenomenon in smelter workers exposed to arsenic. Environ. Res. 39:465-474.
25. Lerman, B. B., Nabil, A., and Green, D. 1980. Megaloblastic, dyserythropoietic anemia following arsenic ingestion. Ann. Clin. Lab. Sci. 10:515-517.
26. Lutz, H. U., Stammler, P., Fasler, S., Ingold, M., and Fehr, J. 1992. Density separation of human red blood cells on self forming Percoll gradients: Correlation with cell age. Biochim. Biophys. Acta 1116:1-10.
27. Ma, H. Z., Sun, T. Z., Xia, Y. J., Yu, G. J., Wang, F. Q., and Fan, A. M. 1997. Endemic arsenic poisoning in Inner Mongolia, China (abstr.). Toxicologist 36:239.
28. Moore, S. A., Moennich, D. M. C., and Gresser, M. J. 1983. Synthesis and hydrolysis of ADP-arsenate by beef heart submitochondrial particles. J. Biol. Chem. 258:6266-6271.
29. Nash, G. B. 1991. Red cell mechanics: What changes are needed to adversely affect in vivo circulation. Biorheology 28:231-239.
30. National Academy of Sciences. 1977. Medical and biological effects of environmental pollutants: Arsenic. Washington, DC: NAS.
31. Rendell, M., Luu, T., Quinlan, E., Knox, S., Fox, M., Kelly, S., and Kahler, K. 1992. Red cell filterabil-ity determined using the cell transit time analyzer (CTTA): Effects of ATP depletion and changes in calcium concentration. Biochem. Biophys. Acta 1133:293-300.
32. Shilo, S., Werner, D., and Hershko, C. 1985. Acute hemolytic anemia caused by severe hypophosphatemia i n diabetic ketoacidosis. Acta Haematol. 73:55-57.
33. Somer, T., and Meiselman, H. J. 1993. Disorders of blood viscosity. Trends Mol. Med. 25:31-39.
34. Squibb, K. S., and Fowler, B. A. 1983. The toxicology of arsenic and its compounds. In Biological and environmental effects of arsenic., ed. B. A. Fowler, pp. 233-269. Amsterdam: Elsevier.
35. Tseng, C.-H., Chong, C.-K., Chen, C.-J., Lin, B. J., and Tai, T.-Y. 1995. Abnormal peripheral microcirculation in seemingly normal subjects living in blackfoot-disease-hyperendemic villages in Taiwan. Int. J. Microcirc. 15:21-27.
36. Tseng, W. P. 1977. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 19:109-119.
37. Vahter, M. 1988. Arsenic. In Biological monitoring of toxic metals, eds. T. W. Clarkson, L. Friberg, G. F. Nordberg, and P. R. Sager, pp. 303-321. New York: Plenum Press.
38. Weed, R. I., LaCelle, P. L., and Merrill, E. W. 1969. Metabolic dependence of red cell deformability. J. Clin. Invest. 48:795-809.
39. Winski, S. L., and Carter, D. E. 1995. Interactions of rat red blood cell sulfhydryls with arsenate and arsenite. J. Toxicol. Environ. Health 46:379-397.
40. Wolf, P. L., and Koett, J. 1980. Hemolytic anemia in hepatic disease with decreased erythrocyte adenosine triphosphate. Am. J. Clin. Pathol. 73:785-788.